Liga tal-aluminju 1350, spiss imsejħa “1350 fojl tal-aluminju”, hija liga ta 'aluminju pur b'kontenut minimu ta' aluminju ta ' 99.5%. Filwaqt li l-aluminju pur mhux komunement użat fl-ippakkjar farmaċewtiku, aluminju u l-ligi tiegħu (inklużi 1350 aluminju) jista 'jintuża fl-ippakkjar farmaċewtiku wara ipproċessar u kisi xierqa.
Pharmaceutical packaging requires certain properties to ensure the safety and preservation of pharmaceuticals, bħal:
Proprjetajiet ta' Ostakolu: Packaging materials should provide a barrier against moisture, ossiġnu, and other environmental factors to protect the drug product.
Sterility: Pharmaceutical packaging should maintain the sterility of the contents and prevent contamination.
Printability: Packaging materials should be capable of high-quality printing to display important information, marka, and instructions.
Ease of sealing: Packaging materials should be easy to seal securely to prevent tampering and maintain product integrity.
Sigurtà: The material should be safe for direct contact with the drug and should not react with the drug or leach harmful substances into the drug.
Fojl tal-aluminju pur (inklużi 1350 aluminju) may not meet all of these requirements without additional processing and coatings. Tipikament, pharmaceutical packaging uses specially treated and coated aluminum foil to enhance its barrier properties, sealing properties and printability.
